Device
EPIFLO
EPIFLO is a medical device with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_2
3
60%
Ph not_applicable
2
40%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
25.0%
1 of 4 finished
Non-Completion Rate
75.0%
3 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(1)
Terminated(3)
Other(1)
Detailed Status
Withdrawn3
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (60.0%)
N/A2 (40.0%)
Trials by Status
withdrawn360%
completed120%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
unknownnot_applicable
Oxygen for Vascular Incisional Healing
NCT03746132
withdrawnphase_2
Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Colon Surgery
NCT02617706
withdrawnnot_applicable
Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Instrumented Fusion
NCT02615379
withdrawnphase_2
TCOT Effectiveness in Preventing Wound Infections in Perineal Resections
NCT02374294
completedphase_2
Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers
NCT01291160
Clinical Trials (5)
Showing 5 of 5 trials
NCT03746132Not Applicable
Oxygen for Vascular Incisional Healing
NCT02617706Phase 2
Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Colon Surgery
NCT02615379Not Applicable
Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Instrumented Fusion
NCT02374294Phase 2
TCOT Effectiveness in Preventing Wound Infections in Perineal Resections
NCT01291160Phase 2
Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5